TLR2 and Parkinson disease: Given its established role in innate immunity, Toll-like receptor 2 may play a key role in microbiome-induced systemic action, and there are several pieces of evidence that the Toll-like receptor 2 signaling pathway is altered in Parkinson’s disease patients.